HIGHLIGHTS
- who: Wei Wang and colleagues from the Department of Hepatobiliary and Pancreatic Surgery, Shanghai Sixth People`s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China have published the paper: Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer, in the Journal: (JOURNAL)
- what: The experiment showed that Escin Ia, the main effective component in SFAC, can reduce LOXL2 activity and promote E-cadherin expression, thereby inhibiting the EMT process of TNBC .
- future: More studies are still required because of the tissue-specific spatial and temporal differences in the expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.